Amber N1 Citations (2)
Originally described in: Cerulean, Venus, and VenusY67C FRET reference standards.Koushik SV, Chen H, Thaler C, Puhl HL, Vogel SS Biophys J. 2006 Dec 15. 91(12):L99-L101. PubMed Journal
Articles Citing Amber N1
| Articles |
|---|
Versatile approach for functional analysis of human proteins and efficient stable cell line generation using FLP-mediated recombination system.
Szczesny RJ, Kowalska K, Klosowska-Kosicka K, Chlebowski A, Owczarek EP, Warkocki Z, Kulinski TM, Adamska D, Affek K, Jedroszkowiak A, Kotrys AV, Tomecki R, Krawczyk PS, Borowski LS, Dziembowski A.
PLoS One. 2018 Mar 28;13(3):e0194887. doi: 10.1371/journal.pone.0194887. eCollection 2018.
PubMed
Associated Plasmids |
| The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative Effect. Klemm N, Schimmer RR, Konrad NK, Thelen F, Fullin J, Topcu E, Koch C, Treacy M, Leventhal MJ, Buhler MM, Lysenko V, Theocharides APA, Kurppa KJ, Balabanov S, Baubec T, Krivtsov AV, Miller PG, Armstrong SA, Ebert BL, Manz MG, Nombela-Arrieta C, Boettcher S. Cancer Res. 2025 Jun 2;85(11):1978-1996. doi: 10.1158/0008-5472.CAN-24-1136. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.